Arcellx (ACLX) Preferred Shares Issued (2021)

Name: Arcellx (ACLX) Preferred Shares Issued (2021) | Business Quant
Creator: Business Quant

Arcellx's quarterly Preferred Shares Issued came in at $37.4 million in Q2 2021, down 54.3% quarter-over-quarter from $81.8 million in Q1 2021.

Arcellx has reported Preferred Shares Issued for 1 years, with the latest figure at $37.4 million in Q2 2021.

For the quarter ending Q2 2021, Preferred Shares Issued changed N/A year-over-year to $37.4 million; the trailing twelve-month figure through Dec 2021 stood at $119.1 million (changed N/A YoY), and the FY2021 full-year result was $119.1 million, changed N/A from the prior year.
Preferred Shares Issued for Q2 2021 stood at $37.4 million, down from $81.8 million in the prior quarter.
The five-year high for Preferred Shares Issued was $81.8 million in Q1 2021, with the low at $37.4 million in Q2 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	-
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	-
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Arcellx	6.48 Bn	6.48 Bn	-	-

Download Data 🔒